Thanks Ohm. It is rare that you make a miscalculation. And, even more rare for you to admit it. (smiley face).

So, for these trials, do you have any concerns? Or, are we on a clear path?

I have one, that no one seems to address.....the drug doesn't work in certain people, and we haven't been able to figure out who those people are so that we can exclude them from the trials. Is there some type of test (e.g. CCR5 expression) that we could run in advance?

Or, am I just wrong in my hypothesis?

You are good at answering multiple questions. Would appreciate you answering the four above. (And, not being a smart ass, although I am sure that I sound like one.) I'm just sitting here wondering why our trials seem good and finish less good.